Moreover, the HCC subtype with active asparagine metabolism shows a higher Tumor Immune Dysfunction and Exclusion (TIDE) score due to the higher levels of immune checkpoint genes (including CTLA4, HAVCR2, LAG3, PDCD1, TIGHT), predicting weak immune-therapy actions. The gene discussed is PDCD1; the disease is hepatocellular carcinoma.